Areas of focus
We concentrate our research and development efforts on our core disease areas listed below and are pursuing multiple drug platforms for these areas.
Innovative science is our passion. Transformational medicines are our goal. Bristol Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, hematology, immunology, cardiovascular and fibrosis.
Therapeutic areas

Oncology
We have pioneered breakthrough medicines that have helped change survival expectations for patients with solid tumor cancers....

Hematology
At Bristol Myers Squibb, we’re advancing blood cancer treatments that have transformational potential ...

Immunology
Bristol Myers Squibb is committed to developing transformational therapies that will lead to long-lasting remission . . .

Cardiovascular
Our deep and long-standing commitment to cardiovascular disease began more than 60 years ago...

Fibrosis
We are researching medicines that have the potential to halt or reverse the progression of fibrosis, the buildup of excessive scar tissue that impairs normal organ function . . .
Drug platforms

Antibody-drug conjugates
By tethering a small molecule to a biologic, antibody-drug conjugates are engineered . . .

Biologics
Biologics are large molecules produced from living organisms . . .

Cell therapy
We have a broad portfolio of CAR T and TCR constructs within...

Drug delivery technology
Novel technologies that will safely and effectively deliver . . .

Epigenetics
We are working to develop a diverse array of therapeutics to target all...

Gene therapy
Gene therapy delivers modified DNA to correct, repair or replace a defective disease-causing gene . . .

Millamolecules
Millamolecules are mid-range compounds that fall in size between small molecules and biologics . . .

Protein homeostasis
We are working to develop cancer treatments directed at key biological...

RNA oligonucleotides
Short strands of nucleic acids synthesized . . .

Small molecules
These are organic compounds that are relatively small in size . . .